Risk Assessment and Management in Cancer Genetics

Authors:

Brand: OUP Oxford

ISBN: 9780198529606

573.30 zł

544.63 zł Save 28.67 zł Tax included

Lowest price within 30 days before promotion: 544.63 zł

Quantity

Product unavailable

Out of print

Notify me about new stock Enter your email address to get notifications about new stock of this product

Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

The need to expand expertise in cancer genetics beyond highly specialized genetics clinics is increasingly being recognized. In response, this practical book provides oncologists, specialist nurses, genetic counsellors, family doctors, and geneticists with comprehensive and easy-to-use guidelines on risk assessment and appropriate management.The book focuses on common familial cancers such as breast, colorectal, ovary, prostate and melanoma, and separate chapters cover cancer predisposing syndromes such as neurofibromatosis, familial adenomatous polyposis and their management.

Product Details

Brand OUP Oxford

Reference 84275

EAN13 9780198529606

ISBN 9780198529606

Data sheet

Publication date: 2005
Issue number: 1
Cover: paperback
Pages count: 288
Dimensions (mm): 168 x 240
Weight (g): 495

Introduction; How to evaluate a family history; Guidelines for referral in Europe; Guidelines for genetic counselling, testing and referral in North America; Principles and applications of gene testing for common cancers; Risk assessment of common malignancies; Risk estimation in breast cancer; Risk estimation in colorectal cancer; Risk estimation in ovarian cancer; Management of familial breast and ovarian cancer in Europe; Management of familial breast and ovarian cancer in North America; Management of familial adenomatous polyposis and other inherited polyposis syndromes; Management of hereditary non-polyposis colorectal cancer; Management and risk assessment of less common familial cancers; Inherited cancer syndromes; The neurofibromatoses; von Hippel-Lindau disease; Multiple endocrine neoplasias; Gorlin Syndrome; The Li-Frameni Syndrome; Other tumour predisposing syndromes; The ethical and insurance issues of cancer genetics;